- Home
- CAC vs CRMD Comparison
CAC vs CRMD Comparison
Compare CAC & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- CRMD
- Stock Information
- Founded
- CAC 1875
- CRMD 2006
- Country
- CAC United States
- CRMD United States
- Employees
- CAC N/A
- CRMD 82
- Industry
- CAC Major Banks
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- CRMD Health Care
- Exchange
- CAC Nasdaq
- CRMD Nasdaq
- Market Cap
- CAC 688.3M
- CRMD 865.2M
- IPO Year
- CAC 1997
- CRMD 2010
- Fundamental
- Price
- CAC $39.82
- CRMD $11.12
- Analyst Decision
- CAC Buy
- CRMD Strong Buy
- Analyst Count
- CAC 3
- CRMD 8
- Target Price
- CAC $48.00
- CRMD $17.57
- AVG Volume (30 Days)
- CAC 56.5K
- CRMD 4.6M
- Earning Date
- CAC 10-28-2025
- CRMD 10-29-2025
- Dividend Yield
- CAC 4.22%
- CRMD N/A
- EPS Growth
- CAC 4.80
- CRMD N/A
- EPS
- CAC 3.11
- CRMD 0.79
- Revenue
- CAC $197,501,000.00
- CRMD $121,484,498.00
- Revenue This Year
- CAC $42.11
- CRMD $404.81
- Revenue Next Year
- CAC $5.51
- CRMD $56.11
- P/E Ratio
- CAC $12.78
- CRMD $14.00
- Revenue Growth
- CAC 21.74
- CRMD 14970.29
- 52 Week Low
- CAC $34.53
- CRMD $5.60
- 52 Week High
- CAC $50.07
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- CAC 47.61
- CRMD 34.64
- Support Level
- CAC $39.82
- CRMD $12.73
- Resistance Level
- CAC $40.75
- CRMD $13.83
- Average True Range (ATR)
- CAC 0.84
- CRMD 0.81
- MACD
- CAC -0.08
- CRMD -0.30
- Stochastic Oscillator
- CAC 16.49
- CRMD 0.90
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.